{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T10:22:37Z","timestamp":1780482157778,"version":"3.54.1"},"reference-count":79,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.com.au","clinicalkey.es","clinicalkey.com","goldjournal.net","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Urology"],"published-print":{"date-parts":[[2024,12]]},"DOI":"10.1016\/j.urology.2024.10.013","type":"journal-article","created":{"date-parts":[[2024,10,9]],"date-time":"2024-10-09T19:29:56Z","timestamp":1728502196000},"page":"310-326","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["A Systematic Review on the Current Landscape of T1 Bladder Cancer Substaging"],"prefix":"10.1016","volume":"194","author":[{"given":"Xabier","family":"P\u00e9rez-Aizpurua","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan Ignacio","family":"Monz\u00f3-Gardiner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oana Beatrice","family":"Popescu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elena","family":"Buend\u00eda-Gonz\u00e1lez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leslie","family":"Cuello-S\u00e1nchez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mar\u00eda","family":"Ca\u00f1adas-Granados","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jaime Jorge","family":"Tufet i Jaumot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joaqu\u00edn","family":"Ruiz de Castroviejo-Blanco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Felipe","family":"Osorio-Ospina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ramiro","family":"Cabello-Benavente","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carmen","family":"Gonz\u00e1lez-Enguita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.urology.2024.10.013_bib1","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1016\/j.urology.2007.06.638","article-title":"Prognostic factors in stage T1 Bladder Cancer: Tumor Pattern (Solid Or Papillary) And Vascular Invasion More Important Than Depth Of Invasion","volume":"70","author":"Andius","year":"2007","journal-title":"Urology"},{"key":"10.1016\/j.urology.2024.10.013_bib2","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1097\/JU.0000000000001422","article-title":"T1 substaging of nonmuscle invasive bladder cancer is associated with bacillus calmette-gu\u00e9rin failure and improves patient stratification at diagnosis","volume":"205","author":"de Jong","year":"2021","journal-title":"J Urol"},{"key":"10.1016\/j.urology.2024.10.013_bib3","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1159\/000506238","article-title":"Sub-staging-specific differences in recurrence-free, progression-free, and cancer-specific survival for patients with T1 bladder cancer: a systematic review and meta-analysis","volume":"104","author":"Chen","year":"2020","journal-title":"Urol Int"},{"key":"10.1016\/j.urology.2024.10.013_bib4","doi-asserted-by":"crossref","first-page":"1437","DOI":"10.1007\/s00345-019-02936-y","article-title":"Prognostic value of T1 substaging on oncological outcomes in patients with non-muscle-invasive bladder urothelial carcinoma: a systematic literature review and meta-analysis","volume":"38","author":"Kardoust Parizi","year":"2020","journal-title":"World J Urol"},{"key":"10.1016\/j.urology.2024.10.013_bib5","first-page":"239.e1","article-title":"Accurate prediction of progression to muscle-invasive disease in patients with pT1G3 bladder cancer: a\u00a0clinical decision-making tool","volume":"36","author":"D\u2032Andrea","year":"2018","journal-title":"Urol Oncol Semin Orig Investig"},{"key":"10.1016\/j.urology.2024.10.013_bib6","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.euf.2016.06.004","article-title":"Feasibility and clinical roles of different substaging systems at first and second transurethral resection in patients with T1 high-grade bladder cancer","volume":"4","author":"Colombo","year":"2018","journal-title":"Eur Urol Focus"},{"key":"10.1016\/j.urology.2024.10.013_bib7","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1016\/S0090-4295(98)00374-4","article-title":"Microstaging of pT1 transitional cell carcinoma of the bladder: identification of subgroups with distinct risks of progression","volume":"52","author":"Smits","year":"1998","journal-title":"Urology"},{"key":"10.1016\/j.urology.2024.10.013_bib8","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1097\/PAP.0000000000000309","article-title":"The genitourinary pathology society update on classification of variant histologies, T1 substaging, molecular taxonomy, and immunotherapy and PD-L1 testing implications of urothelial cancers","volume":"28","author":"Comp\u00e9rat","year":"2021","journal-title":"Adv Anat Pathol"},{"key":"10.1016\/j.urology.2024.10.013_bib9","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1097\/MOU.0000000000000202","article-title":"Prognostic significance of substage and WHO classification systems in T1 urothelial carcinoma of the bladder","volume":"25","author":"Fransen van de Putte","year":"2015","journal-title":"Curr Opin Urol"},{"key":"10.1016\/j.urology.2024.10.013_bib10","doi-asserted-by":"crossref","first-page":"934","DOI":"10.3390\/cancers15030934","article-title":"Prospective validation of the ROL system in substaging pT1 high-grade urothelial carcinoma: results from a mono-institutional confirmatory analysis in BCG treated patients","volume":"15","author":"Valeri","year":"2023","journal-title":"Cancers"},{"key":"10.1016\/j.urology.2024.10.013_bib11","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1097\/PAS.0b013e31823dafd3","article-title":"Prognostic significance in substaging ofT1 urinary bladder urothelial carcinoma on transurethral resection","volume":"36","author":"Chang","year":"2012","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.urology.2024.10.013_bib12","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1016\/S0022-5347(01)65044-4","article-title":"The importance of the depth of invasion in stage T1 bladder carcinoma: a prospective cohort study","volume":"157","author":"Holmang","year":"1997","journal-title":"J Urol"},{"key":"10.1016\/j.urology.2024.10.013_bib13","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1159\/000355358","article-title":"The prognostic value of T1 bladder cancer substaging: a single institution retrospective study","volume":"92","author":"Soukup","year":"2014","journal-title":"Urol Int"},{"key":"10.1016\/j.urology.2024.10.013_bib14","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1038\/bjc.2014.633","article-title":"Reexamining treatment of high-grade T1 bladder cancer according to depth of lamina propria invasion: a prospective trial of 200 patients","volume":"112","author":"Orsola","year":"2015","journal-title":"Br J Cancer"},{"key":"10.1016\/j.urology.2024.10.013_bib15","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1111\/j.1464-410X.2009.08694.x","article-title":"Risk factors for positive findings in patients with high-grade T1 bladder cancer treated with transurethral resection of bladder tumour (TUR) and bacille Calmette-Gu\u00e9rin therapy and the decision for a repeat TUR","volume":"105","author":"Orsola","year":"2010","journal-title":"BJU Int"},{"key":"10.1016\/j.urology.2024.10.013_bib16","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1111\/bju.12364","article-title":"Microarray gene expression profiling and analysis of bladder cancer supports the sub-classification of T1 tumours into T1a and T1b stages","volume":"113","author":"Descotes","year":"2014","journal-title":"BJU Int"},{"key":"10.1016\/j.urology.2024.10.013_bib17","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1159\/000132700","article-title":"Does the expression of fascin-1 and tumor subclassification help to assess the risk of recurrence and progression in t1 urothelial urinary bladder carcinoma?","volume":"80","author":"Soukup","year":"2008","journal-title":"Urol Int"},{"key":"10.1016\/j.urology.2024.10.013_bib18","doi-asserted-by":"crossref","first-page":"1823","DOI":"10.1007\/s12253-019-00767-1","article-title":"Comparative application of different substaging techniques for non-muscle invasive urothelial carcinoma","volume":"26","author":"Eldin","year":"2020","journal-title":"Pathol Oncol Res"},{"key":"10.1016\/j.urology.2024.10.013_bib19","doi-asserted-by":"crossref","first-page":"934","DOI":"10.3390\/cancers15030934","article-title":"Prospective validation of the ROL system in substaging pT1 high-grade urothelial carcinoma: results from a mono-institutional confirmatory analysis in BCG treated patients","volume":"15","author":"Valeri","year":"2023","journal-title":"Cancers"},{"key":"10.1016\/j.urology.2024.10.013_bib20","doi-asserted-by":"crossref","DOI":"10.3389\/fsurg.2021.704902","article-title":"T1 bladder cancer: comparison of the prognostic impact of two substaging systems on disease recurrence and progression and suggestion of a novel nomogram","volume":"8","author":"Asimakopoulos","year":"2021","journal-title":"Front Surg"},{"key":"10.1016\/j.urology.2024.10.013_bib21","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1097\/00005392-200101000-00011","article-title":"The predictive value of muscularis mucosae invasion and p53 over expression on progression of stage T1 bladder carcinoma","volume":"165","author":"Bernardini","year":"2001","journal-title":"J Urol"},{"key":"10.1016\/j.urology.2024.10.013_bib22","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1111\/j.1365-2559.2011.03989.x","article-title":"Substaging by estimating the size of invasive tumour can improve risk stratification in pT1 urothelial bladder cancer-evaluation of a large hospital-based single-centre series","volume":"59","author":"Bertz","year":"2011","journal-title":"Histopathology"},{"key":"10.1016\/j.urology.2024.10.013_bib23","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.humpath.2012.04.020","article-title":"Prognostic factors in T1 bladder urothelial carcinoma: the value of recording millimetric depth of invasion, diameter of invasive carcinoma, and muscularis mucosa invasion","volume":"44","author":"Brimo","year":"2013","journal-title":"Hum Pathol"},{"key":"10.1016\/j.urology.2024.10.013_bib24","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.5858\/arpa.2021-0175-OA","article-title":"Subcategorization of T1 bladder cancer on biopsy and transurethral resection specimens for predicting progression","volume":"146","author":"Budina","year":"2022","journal-title":"Arch Pathol Lab Med"},{"key":"10.1016\/j.urology.2024.10.013_bib25","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1002\/(SICI)1097-0142(19990915)86:6<1035::AID-CNCR20>3.0.CO;2-D","article-title":"Substaging of T1 bladder carcinoma based on the depth of invasion as measured by micrometer: a\u00a0new proposal","volume":"86","author":"Cheng","year":"1999","journal-title":"Cancer"},{"key":"10.1016\/j.urology.2024.10.013_bib26","series-title":"BJU Int","article-title":"Influence of lamina propria invasion extension on T1 high-grade non-muscle-invasive bladder cancer in patients undergoing BCG or radical cystectomy","author":"Contieri","year":"2024"},{"key":"10.1016\/j.urology.2024.10.013_bib27","doi-asserted-by":"crossref","first-page":"575","DOI":"10.3892\/mco.2014.290","article-title":"Prognostic role of substaging in T1G3 transitional cell carcinoma of the urinary bladder","volume":"2","author":"De Marco","year":"2014","journal-title":"Mol Clin Oncol"},{"key":"10.1016\/j.urology.2024.10.013_bib28","first-page":"265","article-title":"Histology and fine structure of the muscularis mucosae of the human urinary bladder","volume":"136","author":"Dixon","year":"1983","journal-title":"J Anat"},{"key":"10.1016\/j.urology.2024.10.013_bib29","doi-asserted-by":"crossref","first-page":"361.e7","DOI":"10.1016\/j.urolonc.2018.05.007","article-title":"Metric substage according to micro and extensive lamina propria invasion improves prognostics in T1 bladder cancer","volume":"36","author":"Fransen van de Putte","year":"2018","journal-title":"Urol Oncol"},{"key":"10.1016\/j.urology.2024.10.013_bib30","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1159\/000515650","article-title":"Substaging of pT1 urothelial bladder carcinoma predicts tumor progression and overall survival","volume":"106","author":"Grobet-Jeandin","year":"2022","journal-title":"Urol Int"},{"key":"10.1016\/j.urology.2024.10.013_bib31","doi-asserted-by":"crossref","unstructured":"Haas M., Engelmann S.U., Mayr R., et al. A novel grading approach predicts worse outcomes in stage pT1 non-muscle-invasive bladder cancer. BJU Int. n\/a(n\/a). doi:10.1111\/bju.16298.","DOI":"10.1111\/bju.16298"},{"key":"10.1016\/j.urology.2024.10.013_bib32","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1016\/0090-4295(94)90134-1","article-title":"Significance of invasion to the muscularis mucosae on the progression of superficial bladder cancer","volume":"43","author":"Hasui","year":"1994","journal-title":"Urology"},{"key":"10.1016\/j.urology.2024.10.013_bib33","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.anndiagpath.2013.11.002","article-title":"Measuring the dimension of invasive component in pT1 urothelial carcinoma in transurethral resection specimens can predict time to recurrence","volume":"18","author":"Hu","year":"2014","journal-title":"Ann Diagn Pathol"},{"key":"10.1016\/j.urology.2024.10.013_bib34","doi-asserted-by":"crossref","first-page":"1120","DOI":"10.1016\/S0022-5347(05)67706-3","article-title":"Outcomes after intravesical bacillus Calmette-Guerin are not affected by substaging of high grade T1 transitional cell carcinoma","volume":"163","author":"Kondylis","year":"2000","journal-title":"J Urol"},{"key":"10.1016\/j.urology.2024.10.013_bib35","doi-asserted-by":"crossref","first-page":"317","DOI":"10.4111\/kju.2012.53.5.317","article-title":"Prognostic significance of substaging according to the depth of lamina propria invasion in primary T1 transitional cell carcinoma of the bladder","volume":"53","author":"Lee","year":"2012","journal-title":"Korean J Urol"},{"key":"10.1016\/j.urology.2024.10.013_bib36","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1097\/PAS.0000000000000964","article-title":"Analysis of T1 bladder cancer on biopsy and transurethral resection specimens: comparison and ranking of T1 quantification approaches to predict progression to muscularis propria invasion","volume":"42","author":"Leivo","year":"2018","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.urology.2024.10.013_bib37","doi-asserted-by":"crossref","first-page":"1182","DOI":"10.1111\/j.1464-410X.2007.07090.x","article-title":"Predicting outcome in minimally invasive (T1a and T1b) urothelial bladder carcinoma using a panel of biomarkers: a\u00a0high throughput tissue microarray analysis","volume":"100","author":"Mhawech-Fauceglia","year":"2007","journal-title":"BJU Int"},{"key":"10.1016\/j.urology.2024.10.013_bib38","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1093\/jjco\/hyt120","article-title":"Clinicopathological analysis of patients with non-muscle-invasive bladder cancer: prognostic value and clinical reliability of the 2004 WHO classification system","volume":"43","author":"Nishiyama","year":"2013","journal-title":"Jpn J Clin Oncol"},{"key":"10.1016\/j.urology.2024.10.013_bib39","doi-asserted-by":"crossref","first-page":"188","DOI":"10.3109\/00365599.2012.719539","article-title":"Population-based study on prognostic factors for recurrence and progression in primary stage T1 bladder tumours","volume":"47","author":"Olsson","year":"2013","journal-title":"Scand J Urol"},{"key":"10.1016\/j.urology.2024.10.013_bib40","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/j.eururo.2005.04.013","article-title":"Initial high-grade T1 urothelial cell carcinoma: feasibility and prognostic significance of lamina propria invasion microstaging (T1a\/b\/c) in BCG-treated and BCG-non-treated patients","volume":"48","author":"Orsola","year":"2005","journal-title":"Eur Urol"},{"key":"10.1016\/j.urology.2024.10.013_bib41","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1111\/iju.13532","article-title":"Infiltrative lamina propria invasion pattern as an independent predictor for cancer-specific and overall survival of instillation treatment-na\u00efve stage T1 high-grade urothelial bladder cancer","volume":"25","author":"Otto","year":"2018","journal-title":"Int J Urol"},{"key":"10.1016\/j.urology.2024.10.013_bib42","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/j.eururo.2011.10.029","article-title":"Female gender and carcinoma in situ in the prostatic urethra are prognostic factors for recurrence, progression, and disease-specific mortality in T1G3 bladder cancer patients treated with bacillus Calmette-Gu\u00e9rin","volume":"62","author":"Palou","year":"2012","journal-title":"Eur Urol"},{"key":"10.1016\/j.urology.2024.10.013_bib43","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1186\/s13000-016-0466-6","article-title":"Usefulness of pT1 substaging in papillary urothelial bladder carcinoma","volume":"11","author":"Patriarca","year":"2016","journal-title":"Diagn Pathol"},{"key":"10.1016\/j.urology.2024.10.013_bib44","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1016\/j.eururo.2015.02.021","article-title":"A molecular pathologic framework for risk stratification of stage T1 urothelial carcinoma","volume":"68","author":"Patschan","year":"2015","journal-title":"Eur Urol"},{"key":"10.1016\/j.urology.2024.10.013_bib45","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1080\/00365590601183055","article-title":"Prognostic value of p53, Ki-67, microstaging and microvessel density in pT1G3 bladder tumors: creation of risk groups for progression","volume":"41","author":"Queipo-Zaragoza","year":"2007","journal-title":"Scand J Urol Nephrol"},{"key":"10.1016\/j.urology.2024.10.013_bib46","doi-asserted-by":"crossref","first-page":"2069","DOI":"10.1016\/j.juro.2012.11.120","article-title":"Prognostic interest in discriminating muscularis mucosa invasion (T1a vs T1b) in nonmuscle invasive bladder carcinoma: French national multicenter study with central pathology review","volume":"189","author":"Roupr\u00eat","year":"2013","journal-title":"J Urol"},{"key":"10.1016\/j.urology.2024.10.013_bib47","first-page":"239","article-title":"The impact of tumor invasion to muscularis mucosae-vascular plexus on patient outcome in pT1 bladder urothelial carcinoma","volume":"92","author":"Sahan","year":"2020","journal-title":"Arch Ital Urol E Androl"},{"key":"10.1016\/j.urology.2024.10.013_bib48","doi-asserted-by":"crossref","first-page":"573","DOI":"10.5858\/arpa.2023-0044-OA","article-title":"pT1 subclassification predicts progression-free survival in en bloc resection of bladder tumor specimens","volume":"148","author":"Sato","year":"2024","journal-title":"Arch Pathol Lab Med"},{"key":"10.1016\/j.urology.2024.10.013_bib49","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1016\/S0090-4295(00)00756-1","article-title":"Prognostic value of P53 nuclear accumulation and histopathologic features in T1 transitional cell carcinoma of the urinary bladder","volume":"56","author":"Shariat","year":"2000","journal-title":"Urology"},{"key":"10.1016\/j.urology.2024.10.013_bib50","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1159\/000063941","article-title":"Microstaging of pT1 transitional cell carcinoma of the bladder. Does it really differentiate two populations with different prognoses? (pT1 subcategory)","volume":"69","author":"S\u00f6zen","year":"2002","journal-title":"Urol Int"},{"key":"10.1016\/j.urology.2024.10.013_bib51","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1590\/s1677-5538.ibju.2017.0424","article-title":"Comparative differences between T1a\/b and T1e\/m as substages in T1 urothelial carcinoma of the bladder","volume":"44","author":"Turan","year":"2018","journal-title":"Int Braz J Urol Off J Braz Soc Urol"},{"key":"10.1016\/j.urology.2024.10.013_bib52","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1016\/j.humpath.2005.06.017","article-title":"A new system for substaging pT1 papillary bladder cancer: a prognostic evaluation","volume":"36","author":"van der Aa","year":"2005","journal-title":"Hum Pathol"},{"key":"10.1016\/j.urology.2024.10.013_bib53","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1016\/j.eururo.2011.10.026","article-title":"A new and highly prognostic system to discern T1 bladder cancer substage","volume":"61","author":"van Rhijn","year":"2012","journal-title":"Eur Urol"},{"key":"10.1016\/j.urology.2024.10.013_bib54","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1111\/j.1464-410X.2012.10996.x","article-title":"Prognostic value of molecular markers, sub-stage and European Organisation for the Research and Treatment of Cancer risk scores in primary T1 bladder cancer","volume":"110","author":"Van Rhijn","year":"2012","journal-title":"BJU Int"},{"key":"10.1016\/j.urology.2024.10.013_bib55","doi-asserted-by":"crossref","first-page":"1622","DOI":"10.1097\/JU.0000000000001630","article-title":"Vertical lamina propria invasion diagnosed by en bloc transurethral resection is a significant predictor of progression for pT1 bladder cancer","volume":"205","author":"Yanagisawa","year":"2021","journal-title":"J Urol"},{"key":"10.1016\/j.urology.2024.10.013_bib56","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1111\/his.14307","article-title":"Feasibility and accuracy of pathological diagnosis in en-bloc transurethral resection specimens versus conventional transurethral resection specimens of bladder tumour: evaluation with pT1 substaging by 10 pathologists","volume":"78","author":"Yanagisawa","year":"2021","journal-title":"Histopathology"},{"key":"10.1016\/j.urology.2024.10.013_bib57","doi-asserted-by":"crossref","first-page":"371","DOI":"10.3233\/BLC-220007","article-title":"Combination of two T1 substaging systems (T1a\/b\/c and T1m\/e) better predicts tumor outcomes in patients with T1 high grade bladder cancer","volume":"8","author":"Yang","year":"2022","journal-title":"Bladder Cancer"},{"key":"10.1016\/j.urology.2024.10.013_bib58","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1007\/s11255-020-02772-9","article-title":"Prognosis of patients with T1 bladder cancer after en bloc transurethral resection of bladder tumor stratified by invasion to the level of the muscularis mucosa","volume":"53","author":"Yasui","year":"2021","journal-title":"Int Urol Nephrol"},{"key":"10.1016\/j.urology.2024.10.013_bib59","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1002\/1097-0142(19900801)66:3<543::AID-CNCR2820660323>3.0.CO;2-R","article-title":"The usefulness of the level of the muscularis mucosae in the staging of invasive transitional cell carcinoma of the urinary bladder","volume":"66","author":"Younes","year":"1990","journal-title":"Cancer"},{"key":"10.1016\/j.urology.2024.10.013_bib60","doi-asserted-by":"crossref","first-page":"3182","DOI":"10.1200\/JCO.1999.17.10.3182","article-title":"Predicting cancer progression in patients with stage T1 bladder carcinoma","volume":"17","author":"Cheng","year":"1999","journal-title":"J Clin Oncol Off J Am Soc Clin Oncol"},{"key":"10.1016\/j.urology.2024.10.013_bib61","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1111\/his.13247","article-title":"Stalk versus base invasion in pT1 papillary cancers of the bladder: improved substaging system predicting the risk of progression","volume":"71","author":"Lawless","year":"2017","journal-title":"Histopathology"},{"key":"10.1016\/j.urology.2024.10.013_bib62","first-page":"517","article-title":"Clinical and biological markers for risk-stratification of T1 high-grade non-muscle invasive bladder cancer","volume":"32","author":"Soria","year":"2022","journal-title":"Curr Opin Urol"},{"key":"10.1016\/j.urology.2024.10.013_bib63","doi-asserted-by":"crossref","first-page":"249","DOI":"10.3109\/00365599209180877","article-title":"Braendstrup O. The muscularis mucosae of the human urinary bladder. Implications for tumor staging on biopsies","volume":"26","author":"Engel","year":"1992","journal-title":"Scand J Urol Nephrol"},{"key":"10.1016\/j.urology.2024.10.013_bib64","article-title":"International Society of Urological Pathology (ISUP) consensus conference on current issues in bladder cancer","volume":"48","author":"Lopez-Beltran","year":"2023","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.urology.2024.10.013_bib65","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1200\/JCO.2014.57.6967","article-title":"Improving selection criteria for early cystectomy in high-grade t1 bladder cancer: a meta-analysis of 15,215 patients","volume":"33","author":"Martin-Doyle","year":"2015","journal-title":"J Clin Oncol Off J Am Soc Clin Oncol"},{"key":"10.1016\/j.urology.2024.10.013_bib66","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.pathol.2020.09.014","article-title":"Stage T1 bladder cancer: diagnostic criteria and pitfalls","volume":"53","author":"Lopez-Beltran","year":"2021","journal-title":"Pathology"},{"key":"10.1016\/j.urology.2024.10.013_bib67","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/s00428-020-02808-6","article-title":"pT1 high-grade bladder cancer: histologic criteria, pitfalls in the assessment of invasion, and substaging","volume":"477","author":"Raspollini","year":"2020","journal-title":"Virchows Arch"},{"key":"10.1016\/j.urology.2024.10.013_bib68","doi-asserted-by":"crossref","first-page":"3377","DOI":"10.1158\/1078-0432.CCR-12-0077-T","article-title":"A molecular taxonomy for urothelial carcinoma","volume":"18","author":"Sj\u00f6dahl","year":"2012","journal-title":"Clin Cancer Res Off J Am Assoc Cancer Res"},{"key":"10.1016\/j.urology.2024.10.013_bib69","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1016\/j.eururo.2005.12.031","article-title":"Predicting recurrence and progression in individual patients with stage Ta T1 bladder cancer using EORTC risk tables: a combined analysis of 2596 patients from seven EORTC trials","volume":"49","author":"Sylvester","year":"2006","journal-title":"Eur Urol"},{"key":"10.1016\/j.urology.2024.10.013_bib70","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1016\/j.eururo.2020.12.033","article-title":"European Association of Urology (EAU) Prognostic Factor Risk Groups for Non\u2013muscle-invasive Bladder Cancer (NMIBC) incorporating the WHO 2004\/2016 and WHO 1973 Classification Systems For Grade: An Update From the EAU NMIBC guidelines panel","volume":"79","author":"Sylvester","year":"2021","journal-title":"Eur Urol"},{"key":"10.1016\/j.urology.2024.10.013_bib71","doi-asserted-by":"crossref","first-page":"2195","DOI":"10.1016\/j.juro.2009.07.016","article-title":"Predicting nonmuscle invasive bladder cancer recurrence and progression in patients treated with Bacillus Calmette-Guerin: the CUETO scoring model","volume":"182","author":"Fernandez-Gomez","year":"2009","journal-title":"J Urol"},{"key":"10.1016\/j.urology.2024.10.013_bib72","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-021-97500-3","article-title":"Tumor budding correlates with tumor invasiveness and predicts worse survival in pT1 non-muscle-invasive bladder cancer","volume":"11","author":"Eckstein","year":"2021","journal-title":"Sci Rep"},{"key":"10.1016\/j.urology.2024.10.013_bib73","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1111\/bju.13146","article-title":"Comparing long-term outcomes of primary and progressive carcinoma invading bladder muscle after radical cystectomy","volume":"117","author":"Moschini","year":"2016","journal-title":"BJU Int"},{"key":"10.1016\/j.urology.2024.10.013_bib74","doi-asserted-by":"crossref","first-page":"7543","DOI":"10.1038\/s41598-018-26002-6","article-title":"Oncological outcome of primary and secondary muscle-invasive bladder cancer: a systematic review and meta-analysis","volume":"8","author":"Ge","year":"2018","journal-title":"Sci Rep"},{"key":"10.1016\/j.urology.2024.10.013_bib75","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.eururo.2005.03.021","article-title":"Cystectomy in patients with high risk superficial bladder tumors who fail intravesical BCG therapy: pre-cystectomy prostate involvement as a prognostic factor","volume":"48","author":"Huguet","year":"2005","journal-title":"Eur Urol"},{"key":"10.1016\/j.urology.2024.10.013_bib76","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1016\/j.eururo.2021.09.018","article-title":"Health-related quality of life for patients undergoing radical cystectomy: results of a large prospective cohort","volume":"81","author":"Clements","year":"2022","journal-title":"Eur Urol"},{"key":"10.1016\/j.urology.2024.10.013_bib77","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/j.suronc.2016.05.027","article-title":"A systematic review and meta-analysis of quality of life outcomes after radical cystectomy for bladder cancer","volume":"25","author":"Yang","year":"2016","journal-title":"Surg Oncol"},{"key":"10.1016\/j.urology.2024.10.013_bib78","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.euf.2019.04.002","article-title":"Recurrence rate and cost consequence of the shortage of bacillus Calmette-Gu\u00e9rin connaught strain for bladder cancer patients","volume":"7","author":"Ourfali","year":"2021","journal-title":"Eur Urol Focus"},{"key":"10.1016\/j.urology.2024.10.013_bib79","doi-asserted-by":"crossref","first-page":"1955","DOI":"10.1016\/S0002-9440(10)64665-2","article-title":"Frequent FGFR3 mutations in papillary non-invasive bladder (pTa) tumors","volume":"158","author":"Billerey","year":"2001","journal-title":"Am J Pathol"}],"container-title":["Urology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S009042952400880X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S009042952400880X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,12,4]],"date-time":"2024-12-04T15:02:01Z","timestamp":1733324521000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S009042952400880X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12]]},"references-count":79,"alternative-id":["S009042952400880X"],"URL":"https:\/\/doi.org\/10.1016\/j.urology.2024.10.013","relation":{},"ISSN":["0090-4295"],"issn-type":[{"value":"0090-4295","type":"print"}],"subject":[],"published":{"date-parts":[[2024,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A Systematic Review on the Current Landscape of T1 Bladder Cancer Substaging","name":"articletitle","label":"Article Title"},{"value":"Urology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.urology.2024.10.013","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}